Involvement of prostaglandins in the nicotine-induced pituitary-adrenocortical response during social stress

Journal of Physiology and Pharmacology

Volumn 53, Issue 4 II, 2002, Pages 847-857

  Bugajski, J ^a   Gadek Michalska A ^a   Bugajski, A J ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

ACTH and corticosterone secretion; COX 1; COX 2; Nicotine; Nicotinic acetylcholine receptors; Prostaglandins; Social stress

Indexed keywords

ATROPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTERONE; CORTICOTROPIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MECAMYLAMINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; CROWDING; DRUG SELECTIVITY; ENZYME ACTIVITY; EVOKED RESPONSE; HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; RAT; RECEPTOR UPREGULATION; SOCIAL BEHAVIOR;

ADAPTATION, PHYSIOLOGICAL; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CHOLINERGIC ANTAGONISTS; CORTICOSTERONE; CROWDING; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; ISOENZYMES; MALE; MEMBRANE PROTEINS; NICOTINE; PITUITARY-ADRENAL SYSTEM; POPULATION DENSITY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, WISTAR; RECEPTORS, NICOTINIC; SOCIAL ENVIRONMENT; STRESS; STRESS, PSYCHOLOGICAL;

EID: 0036913125     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Taylor P, Brown JH. Acetylcholine. Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 5th Edition, ed by GJ Siegel et al. Raven Press, Ltd., New York, Chapter 11, 231-260.
2. Luetje CW, Patrick J, Seguela P. Nicotine receptors in the mammalian brain. FASEB J 1990; 4: 2753-2760.
3. Gotti C, Fomasari D, Clementi F. Human neuronal nicotinic receptors. Progress in Neurobiology 1997; 53: 199-237.
4. Zhu W, Umegaki H, Yoshimura J, Tamaya N, Suzuki Y, Miura H, Iguchi A. The elevation of plasma adrenocorticotropic hormone and expression of c-Fos in hypothalamic paraventricular nucleus by microinjection of neostygmine into the hippocampus in rats: Comparision with acute stress responses. Brain Res 2001; 892: 391-395.
5. Zhu W, Umegaki H, Suzuki Y, Miura H, Iguchi. Involvement of the bed nucleus of the stria terminalis in hippocampal cholinergic system-mediated activation of the hypothalamo-pituitary-adrenocortical axis in rats. Brain Res 2001; 916: 101-106.
6. Matta SG, Fu Y, Valentine JD, Sharp BM. Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998; 23: 103-113.
7. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. A single corticosterone pretreatmant inhibits the hypothalamic-pituitary-adrenal responses to adrenergic and cholinergic stimulation. J Physiol Pharmacol 2001; 52: 313-324.
8. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2002; 53: 453-462.
9. Mizuno T, Kimura F. Attenuated stress response of hipocampal acetylcholine release and adrenocortical secretion in aged rats. Neuroscience Lett 1997; 222: 49-52.
10. Peck JA, Dilsaver SC, McGee M. Chronic forced swim stress produces subsensitivity to nicotine. Pharmacol Biochem Behav 1991; 38: 501-504.
11. Takita M, Muramatsu I. Alteration of brain nicotinic receptors induced by immobilization stress and nicotine in rats. Brain Res 1995; 681: 190-192.
12. Ga̧dek-Michalska A, Bugajski J, Borycz J, Bugajski AJ, Głód R. Social crowding stress attenuates central histamine and muscarinic cholinergic system involved in the hypothalamic-pituitary-adrenocortical responsiveness. Neurosci Res Commun 1994; 15: 59-68.
13. 2 in the rat. Prostaglandins, Leukotriens and Essential Fatty Acids 1997; 56: 165-168.
14. Karanth S, Lyson K, McCann SM. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus. Neuroimmunomodulation 1999; 3: 168-174.
15. McCann SM, Kimura M, Yu WH, Mastronardi CA, Rettori V, Karanth S. Cytokines and pituitary hormone secretion. Vitamins and Hormones vol 63. Academic Press, San Diego, USA 2001; 29-62.
16. Katori M, Majima M. Cyclooxygenase-2 its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000; 49: 367-392.
17. Hoffman C. COX-2 in brain and spinal cord - Implications for therapeutics. Curr Med Chem 2000; 7: 1113-1120.
18. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-386.
19. Bugajski J, Ga̧dek-Michalska A, Borycz J, Głód R. Effect of indomethacin on nicotine-induced ACTH and corticosterone response. J Physiol Pharmacol 1998; 49: 165-173.
20. 3H]norepinephrine release from rat hippocampal slices. Neurochem Res 2001; 26: 943-950.
21. Sziraki I, Sershen H, Benuck M, Hashim A, Lajtha A. Receptor systems participating in nicotine-specific effects. Neurochem Int 1998; 33: 445-457.
22. Savci V, Sibel Gurun M, Ulus IH, Kiran BK. Effect of intracerebroventricularly injected choline on plasma ACTH and β-endorphin levels in conscious rats. Eur J Pharmacol 1996; 309: 275-280.
23. Okuda H, Shioda S, Nakai Y, Nakayama H, Okamoto M, Nakashima T. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neurosci Lett 1993; 161: 183-186.
24. Ga̧dek-Michalska A, Bugajski J, Bugajski AJ, Głód R. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity. J Physiol Pharmacol 2002; 53: 275-287.
25. Galzi JL, Changeux JP. Neurotransmitter receptors VI. Neuronal nicotinic receptors: Molecular organization and regulations. Neuropharmacology 1995; 34: 563-582.
26. Cam GR, Bassett JR. Effect of prolonged exposure to nicotine and stress on the pituitary-adrenocortical response; the possibility of cross-adaptation. Pharmacol Biochem Behav 1984; 20: 221-226.
27. Saareks V, Riutta A, Alanko J, Ylitalo P, Parviainen M, Mucha I, Sievi E, Vapaatalo H. Clinical pharmacology of eicosanoids, nicotine induced changes in man. J Physiol Pharmacol 2000; 51: 631-642.
28. Bugajski J, Głód R, Ga̧dek-Michalska A, Bugajski AJ. Involvement of constitutive (COX-1) and inducible cyclooxygenase (COX-2) in the adrenergic-induced ACTH and corticosterone secretion. J Physiol Pharmacol 2001; 52: 795-806.
29. Bugajski J, Ga̧dek-Michalska A, Gł̊d R, Bugajski AJ. Effect of social stress on COX-1 and COX-2-induced alterations in the adrenergic agonists-evoked hypothalamic-pituitary-adrenal responses. J Physiol Pharmacol 2001; 52: 811-822.
30. Morimoto A, Watanabe T, Morimoto K, Nakamori T, Murakami N. Possible involvement of prostaglandins in psychological stress-induced responses in rats. J Physiol Lond 1991; 443: 421-429.
31. 2 is involved in adrenocorticotrophic hormone release during swimming exercise in rats. J Physiol Lond 1991; 433: 719-725.